Cabergoline vs pramipexole

Cabergoline and Pramipexole are medications used in managing Parkinson’s disease and restless legs syndrome, but they differ in classes and profiles. Cabergoline, a long-acting dopamine agonist, is mainly used to lower prolactin levels, while Pramipexole is a non-ergoline dopamine agonist better suited for addressing Parkinson’s motor symptoms. Both demand careful side-effect monitoring, with choices guided by medical needs and therapeutic goals.

Select Wishlist

    Left Menu Icon
    Your Cart